However, the few studies that have previously assessed circulating levels of IL-18 in NAFL compared to NASH patients and taken the metabolic status of patients into consideration have not been able to demonstrate any differences (30, 31). The gene discussed is IL18; the disease is metabolic dysfunction-associated steatohepatitis.